Article
Response to Prolonged Duration of Therapeutic Dose Oral Iron Therapy in a Girl With Novel TMPRSS6 Gene Variants: A Case Report and Review Literature.
Journal of pediatric hematology/oncology - 1 Jan 2023
Udomponglukkana Rawinun, Sasanakul Werasak, Tangbubpha Noppawan, Chuansumrit Ampaiwan, Tim-Aroon Thipwimol, Pongphitcha Pongpak, Sirachainan Nongnuch
Abstract excerpt
Iron-refractory iron deficiency anemia (IRIDA) is an autosomal recessive disorder caused by mutations in the TMPRSS6 gene, which impair iron homeostasis. We reported a 4-year-old girl who presented with a 1-year history of iron deficiency anemia. Her hemoglobin level increased from 6.5 g/dL to 12.6 g/dL with a prolonged duration of therapeutic dose oral iron therapy (5 mg/kg/d), and the level remained quite...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
